Amphastar Pharmaceuticals (AMPH) Current Taxes (2013 - 2026)

Amphastar Pharmaceuticals has reported Current Taxes for 14 years, with the latest figure at $546000.0 in Q2 2026.

• On a quarterly basis, Current Taxes fell 47.95% year-over-year to $546000.0 in Q2 2026; TTM through Jun 2026 was $546000.0, a 47.95% decrease from a year earlier, with the FY2025 full-year figure at $239000.0, down 97.53% from the prior year.
• Current Taxes was $546000.0 for Q2 2026 at Amphastar Pharmaceuticals, up from $414000.0 in the prior quarter.
• The five-year high for Current Taxes was $31.1 million in Q3 2023, with the low at $239000.0 in Q4 2025.
• Average Current Taxes over 5 years is $6.8 million, with a median of $3.1 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Current Taxes jumped 2864.15% in 2023, then sank 97.53% in 2025.
• Over 5 years, Current Taxes stood at $4.6 million in 2022, then slumped by 64.8% to $1.6 million in 2023, then jumped by 500.62% to $9.7 million in 2024, then tumbled by 97.53% to $239000.0 in 2025, then surged by 128.45% to $546000.0 in 2026.
• The last three Current Taxes figures came in at $546000.0 (Q2 2026), $414000.0 (Q1 2026), and $239000.0 (Q4 2025), per Business Quant data.